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Abstract
Background Pilocytic astrocytoma can be challenging to
diagnose.
Methods Its clinical presentations can differ, directly related to its
size and location, and are relatively unreliable. Similarly, imaging
findings also vary with the location of the pilocytic astrocytoma.
Results This review provides an overview of the different
imaging findings regarding pilocytic astrocytomas using both
conventional and advanced magnetic resonance imaging se-
quences according to tumour location; the findings are strong-
ly related to the tumour’s tendency to infiltrate surrounding
structures, being able to carry out gross total resection, and
finally the prognosis.
Conclusions Knowledge of these imaging manifestations of
pilocytic astrocytoma may be helpful to arrive at an accurate
diagnosis.
Teaching Points
• To recognise the various imaging findings of pilocytic astro-
cytoma on both conventional and advanced magnetic reso-
nance imaging sequences.
• To identify the characteristic imaging findings according to
tumour location.
• To discuss the relevant differential diagnoses of pilocytic
astrocytoma in each tumour location.
Keywords Pilocytic astrocytoma . Glioma .Magnetic
resonance imaging
Introduction
Pilocytic astrocytoma (PA) is a rare, slow-growing glio-
ma, classified as grade I by the World Health Organisation
(WHO); it typically occurs in children and young adults
[1, 2]. PA is the most common glial neoplasm in children.
Only one-third of patients are older than 18 years of age
and only 17 % are older than 30 years of age. In the
paediatric population, two-thirds of lesions are located in
the cerebellum; in adults, one-half of tumours are
supratentorial [3, 4]. The cerebellum and the region
around the third ventricle are the most common sites of
origin; however, the entire neuraxis can be affected, with
a preference for the optic nerve, optic chiasma, hypothal-
amus, cerebellum, brainstem, thalamus, basal ganglia, and
cerebral hemispheres [5–7].
There are no clinical features that are unique to these
tumours. Signs and symptoms are usually of several months’
duration and are directly related to the size, location, and
presence of associated hydrocephalus. PAs usually follow an
indolent course, with an extremely high survival rate—over
90 % at 10 years of age [8].
The macroscopic appearance of PAs is typically well-
circumscribed, cystlike masses with a discrete mural nodule
[9]. The name “pilocytic” (directly translated as “hair cell”) is
derived from the long, hair-like projections that emanate from
the neoplastic astrocytes. Microscopically, this tumour often
reveals a biphasic pattern in which more compact areas com-
posed of bipolar areas and brightly eosinophilic Rosenthal
fibers alternate with looser, spongier areas with prominent
microcysts. Eosinophilic granular bodies are found in both
compact and loose areas (Fig. 1a-c). Pleomorphism,
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Fig. 1 Pilocytic astrocytoma is characterised by a biphasic compact (*) and looser, microcystic areas (+); haematoxylin & eosin (H&E) 40×. b High
magnification of eosinophilic granular bodies (arrowheads) and Rosenthal fibers (arrows); H&E 400×. cHigher magnification of the loose area; H&E 100×
Fig. 2 Pilomyxoid astrocytoma. a Piloid cells in a loosemyxoid stroma (asterisks); H&E 100×.b Perivascular arrangement of neoplastic cells (arrow); 400×
388 Insights Imaging (2014) 5:387–402
infrequent mitosis, or vascular proliferation may be ob-
served; however, unlike other astrocytomas, they are
rather degenerative and do not have an ominous prog-
nosis. Hyalinisation of the blood vessels is another
feature of PAs. Microvascular proliferation of PAs ac-
counts for the contrast enhancement that accompanies
these tumours on cross-sectional imaging.
A PAwith anaplastic features often contains more than four
mitoses per ten high-powered fields, as well as
pseudopalisading necrosis. While PAs with anaplastic features
do not have defined criteria under the WHO classification,
evidence suggests that PAs with anaplastic features and
pseudopalisading necrosis behave similarly to WHO grade 3
neoplasms.
Pilomyxoid astrocytoma (PMA) is a recently described
astrocytic tumour that has been previously diagnosed as
pilocytic astrocytoma. PMA can be defined as either a variant
of PA or a separate entity with monomorphous pilomyxoid
characteristics. PMA is a grade II tumour characterised by a
prominent myxoid stroma and angiocentric arrangement of
neoplastic cells (Fig. 2a, b). More aggressive than PA, PMA
more often exhibits local recurrence, as well as cerebrospinal
spreading [10].
When imaged in cross section, two-thirds of all PAs dem-
onstrate a classic appearance: a cystic mass with an enhancing
mural nodule. However, less common appearances are quite
nonspecific. A feature specific of this benign neoplasm is that
in many cases it displays histological and imaging features
Fig. 3 Juvenile pilocytic astrocytoma of the cerebellum in a 5-year-old
girl. a Post-contrast CT shows a cystic lesion involving the right cerebel-
lar hemisphere with a hypodense cystic component (asterisks) and a large,
solid, isodense component (arrows). b On axial T1-weighted image, the
solid component is homogeneous and hypointense compared with the
grey matter (arrows). c On T2-weighted images, the solid component
appears hyperintense compared with the grey matter and slightly
hypointense compared with the cerebrospinal fluid (arrows). Post-con-
trast axial (d) and sagittal (e) images demonstrate heterogeneous enhance-
ment of the solid component of the mass with areas that remain
unenhanced (s) and areas with nodular enhancement (arrowheads). Note
the cystic components (c)
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that are commonly seen in higher grade neoplasms and appear
incongruous for a slow-growing brain tumour with fairly
bland histological characteristics, such as microvascular pro-
liferation, infiltration of surrounding tissues and structures,
intratumoral haemorrhage, intense enhancement on post-
contrast images, and leptomeningeal dissemination [2, 9,
11–13].
Although gross total resection of the tumour is often cura-
tive, location in critical or deep areas (such as the brainstem
and hypothalamus) can render it unresectable and require
Fig. 4 A pilocytic astrocytoma of the right cerebellar hemisphere inci-
dentally discovered during staging in a 45-year-old woman with breast
cancer. a An axial CT image shows a well-marginated cyst in the right
cerebellar hemisphere (arrow). b An axial CT image in a higher level
shows fleck-like calcifications (arrowheads). On sagittal T2-weighted (c),
coronal FLAIR (d), and axial diffusion-weighted (e) images, the cyst
follows cerebrospinal fluid intensity (arrows). This axial post-contrast T1-
weighted image (f) depicts an enhancing focus (arrow). On MRS centred
on an enhancing nodule with TE 144-ms (g, h), there is mild elevation of
choline/Cr, mild reduction of NAA/Cr, and a small lactate peak
Fig. 5 A large, cystic CPA in a 7-year-old boy. (a)An axial T2-weighted
image shows a hyperintense mass of the right cerebellar hemisphere with
a less intense soft-tissue nodule along its medial margin and without
surrounding oedema (arrows). Note the arachnoid cyst in the left middle
cranial fossa. b On an axial FLAIR image, the cystic component shows
low signal intensity that is higher than that of the CSF, and the soft tissue
nodule is homogeneous and slightly hyperintense (arrows). c On a
diffusion-weighted image, the mural nodule appears isointense (arrow).
d An axial, contrast-enhanced, T1-weighted image demonstrates intense
enhancement of the mural nodule (arrows)
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additional management approaches. Strategies for treating PA
in critical or deep areas, such as chiasmatic and brainstem PAs,
include observation and combinations of surgery, chemother-
apy, and radiotherapy. Although pathological diagnosis re-
mains the gold standard, preoperative diagnosis of tumour
behaviour and extent is of utmost importance in selecting
the appropriate therapeutic management in every single case
[14]. Quite often, the diagnosis of PA is initially made or
suggested on the basis of an imaging study. Therefore, it is
important for all radiologists to be aware of the many clinical
and radiological manifestations of this tumour type.
The aim of this pictorial review is to illustrate the wide
spectrum of radiologic manifestations of PAs on both
conventional and advanced magnetic resonance imaging
(MRI) sequences according to tumour location.
Infratentorial manifestations
Cerebellar PA
Cerebellar PA (CPA) is the most common cerebellar tumour in
children [15]. The peak incidence of CPA is between the ages
of 5 and 13 years. CPA occurs with equal frequency in boys
and girls. Although CPA is usually sporadic, associations with
Fig. 6 Pilocytic astrocytoma in a
26-year-old woman arising in the
vermis. a A sagittal T2-weighted
image shows a hyperintense
cystic mass of the cerebellar
vermis with a peripherally located
mural nodule (arrows)
compressing the fourth ventricle.
b An axial contrast-enhanced T1-
weighted image demonstrates
intense enhancement of the mural
nodule (arrow), as well as cyst
wall enhancement (arrowheads)
Fig. 7 A pilocytic astrocytoma with a predominantly solid mass and a
minimal cyst-like component in a 14-year-old girl. a This coronal T2-
weighted image shows a large, well-marginated mass, involving the
vermis and both cerebellar hemispheres that effaces the fourth ventricle.
b On an axial FLAIR image, the solid mass shows high signal intensity
with hypointense cystic areas (arrows). c On an axial contrast-enhanced
image, the mass shows inhomogeneous contrast enhancement, with nod-
ules that exhibit intense enhancement (arrows) and other cystic areas that
remain unenhanced (arrowheads)
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neurofibromatosis type 1, Turcot syndrome, PHACE(S) syn-
drome, and Ollier’s disease have been reported [16].
There is contradictory evidence in the literature regarding
the most common location of PA in the cerebellum. In one
series of 132 patients, 16 % of tumours arose in the vermis,
53 % in the cerebellar hemisphere, and 26 % in both; 34 %
also involved the brainstem [17]. However, in another review
of 168 cases, 71 % of PA tumours were located in the vermis,
while 29 % occurred in the hemisphere [18].
Because PA growth is generally slow, affected children
usually present with a long history of waxing and waning
signs of increased intracranial pressure. Headache, vomiting,
gait disturbance, blurred vision, diplopia, and neck pain are
common symptoms in patients with CPA [16].
CPAs can be small or very large, and cystic, solid, or solid
with a necrotic center. Typical computed tomography (CT)
imaging features are a large and predominantly cystic mass
arising from the vermis cerebelli or the cerebellar hemi-
spheres. The solid part appears hypodense or isodense (or,
less commonly, hyperdense) and enhanced on post-contrast
images [18, 19] (Fig. 3a). Tumour calcification is rare, but
tends to resemble flecks when it does occur [15] (Fig. 4a,b).
The appearance of PA on MRI is variable and depends on
the tumour’s size and structure. Four predominant imaging
patterns of PA have been described: a mass with a non-
enhancing cyst and an intensely enhancing mural nodule
(Figs. 4 and 5); a mass with an enhancing cyst wall and an
intensely enhancing mural nodule (Fig. 6); a necrotic mass
Fig. 8 Pilocytic astrocytoma of the left cerebellar hemisphere with a
solid and cystic component severely compressing the fourth ventricle and
the medulla, producing obstructive hydrocephalus. aAn axial T2-weight-
ed image shows a cystic, hyperintense mass with a less intense solid
component (asterisks) compressing the fourth ventricle (arrow). b On a
FLAIR image, the cystic component (c) shows low signal intensity, which
is higher than that of the CSF, and the solid component (s) shows high
signal intensity. Note the low signal of the compressed fourth ventricle
(arrow) and the peritumoral oedema (e). cOn this T1-weighted image, the
solid components appear hypointense compared with grey matter. d The
solid component shows high values on an ADC map. e Intense enhance-
ment of solid components is depicted after the administration of a para-
magnetic agent
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with a central non-enhancing zone; and a predominantly solid
mass with minimal to no cystlike component [9] (Figs. 7 and
8). Solid, non-necrotic tumours are less common and account
for approximately 10 % of cases. However approximately
50 % of the tumours are cystic, with a mural nodule attached
to one part of the cyst wall [15] (Fig. 5).
The solid component of PAs can be homogeneous or
heterogeneous. It is usually hypo- to isointense on T1-
weighted MRI and hyperintense on T2-weighted/FLAIR im-
ages compared with grey matter. Compared with the cerebro-
spinal fluid, the solid component is isointense on T2-weighted
images and hyperintense on FLAIR images [20]. After the
Fig. 9 Focal midbrain glioma, a histopathologically proven pilocytic
astrocytoma in an 11-year-old boy. Sagittal (a) and axial (b) T2-weighted
images show an exophytic, sharply marginated, hyperintense mass in-
volving the right cerebral peduncle. No surrounding oedema is identified.
On this T1-weighted image (c), the mass is isointense comparedwith grey
matter. The mass is isointense on diffusion-weighted imaging (d). An
axial post-contrast image (e) shows heterogeneous enhancement of the
tumour. Proton MRS with TE 144-ms (f, g) revealed high choline/Cr
(2.46) and NAA/Cr ratios (1.27)
Fig. 10 Midbrain pilocytic astrocytoma in a 20-year-old woman. A
sagittal T2-weighted image (a) shows exophytic growth of the tumour.
An axial, post-contrast, T1-weighted (b) image shows intense contrast
enhancement (arrows). On proton MRS with TE 144 ms (c, d),
"pseudomalignant" spectrum is observed with an elevated choline peak
and reduction of the NAA peak, choline/Cr ratio (3.17), and NAA/Cr
ratio (2.55)
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administration of a paramagnetic agent, the solid component
of PAs exhibits variable enhancement patterns: areas with
prominent enhancement as well as areas that remain
unenhanced. Yet the cystic component appears isointense on
T1- and T2-weighted images and hyperintense on FLAIR
images compared with cerebrospinal fluid (CSF) signal inten-
sity. Enhancement of the cyst wall is not always present and is
not necessarily indicative of tumour involvement.
Haemorrhages have rarely been reported in PAs and are
usually not massive.
On diffusion-weighted imaging, cystic components of the
mass exhibit the diffusion properties of CSF. The solid com-
ponent displays high apparent diffusion coefficient (ADC)
values, which indicate the low cellularity of PA [21]. Pavlisa
et al. report that ADC values greater than 120×10−5 mm2/s are
indicative of PA, while an ADC between 80 and 120×
10−5 mm2/s is characteristic of ependymoma. Myeloblastoma
usually exhibits strong restriction, with ADC less than 80×
10−5 mm2/s [22] (Figs. 4e, 5c and 8d).
Reported studies that employ magnetic resonance spec-
troscopy (MRS) to examine CPA have revealed high
choline, high lactate, and low N-acetylaspartate (NAA)
levels, features that are usually associated with high-
grade tumours. The presence of lactate within pilocytic
tumours might be explained by several mechanisms, such
as an abnormal number or dysfunction of mitochondria
(which would interfere with the processes of oxidative
phosphorylation and electron transport); alterations in pro-
portional oxygen delivery, oxygen extraction, or oxygen
usage by the tumour; or anaerobic glycolysis by tumour
cells [23, 24]. However, an in vivo study of PAs using
proton MRS by Sutton et al. reported a choline/NAA ratio
of 1.80, which is lower than the ratio observed in other
studies [25] (Figs. 4g,h). Although investigators report
Fig. 11 A pilocytic astrocytoma extending to the upper cervical spine
with dissemination after partial resection. a Sagittal T2-weighted and b
axial T2-weighted images at the level of the foramen magnum show a
high-signal cyst-like mass (arrows). c The lesion is hypointense on
diffusion-weighted imaging (arrows). Contrast-enhanced axial (d) and
sagittal T1-weighted (e) images of the brain show inhomogeneous en-
hancement of the mass (arrows), as well as diffuse enhancement of the
basilar cisternal spaces (arrowheads)
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that cerebellar PA with anaplastic features is more often
solid than cystic from a neuroimaging standpoint, CT and
MRI findings are inadequate to predict these histologic
features.
Differential diagnosis of CPA in children mainly includes
ependymoma and medulloblastoma. Ependymomas might
have calcifications (50 %) and tend to extend laterally to the
cerebellopontine angles, while medulloblastomas tend to dis-
seminate through the CSF spaces to the brain and spine.
Rumboldt et al. [21] reported the contribution of ADC in the
differentiation of paediatric cerebellar tumours and proposed
that ADC values >1.4 are more consistent with PA, while
values <0.9 are more suggestive of medulloblastoma. In
adults, the differential diagnosis of a cerebellar partially cystic
mass should also include metastasis (usually known primary)
and haemangioblastoma, apart from PA.
Investigators have demonstrated marked elevation of
relative cerebral blood volume (rCBV) in cases of
haemangioblastoma and mild elevation in cases of PA,
with statistically significant differences. Kumar et al.
reported mean relative cerebral blood volumes of 7.7
in patients with haemangioblastomas and 1.8 in patients
with PAs. Therefore, a finding of elevated rCBV levels
should lead to a high preoperative suspicion of
haemangioblastoma [26].
Gross total resection is the treatment of choice for
CPA and is often curative. Progression of residual dis-
ease can be controlled by tumour re-excision and ste-
reotactic radiosurgery [27, 28]. In the event of biopsy-
proven pilocytic astrocytoma with anaplastic features,
radiation therapy and/or chemotherapy will be required
[12].
Fig. 12 A pilocytic astrocytoma involving optic pathways. a An axial
T2-weighted image shows a large mass originating in the region of the
optic chiasm/hypothalamus (arrows). Note the arachnoid cyst in the right
middle cranial fossa (arrowheads). b An axial T2-weighted image in a
higher level shows the hyperintense tumour extending to the optic radi-
ations (arrows). On this T1-weighted image (c), the mass is isointense
compared with grey matter. T1-weighted axial (d) and sagittal (e) post-
contrast images show heterogeneous enhancement extending anteriorly
towards the optic nerves and posteriorly towards the optic tracts. Note the
enhancing nodule dorsal to the medulla due to dissemination of the
pilocytic astrocytoma (arrows)
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Brainstem PA
Brainstem tumours (BSTs) account for 10–15 % of primary
intracranial tumours in children. They occur at a mean age of
7 years and are usually divided between diffuse BSTs and
non-diffuse or focal BSTs. BSTs are almost exclusively astro-
cytomas. Diffuse BSTs are usually fibrillary astrocytomas or
malignant neoplasms, while focal BSTs are mainly PAs.
PA of the brainstem (BPA) in children can be located in the
midbrain (in the pons), but is more frequently located in the
medulla. Involvement of the upper cervical cord is sometimes
noted [29–31]. Adult BPA is very rare. Guillamo et al. [32]
report only a single case of PA in 32 biopsied adult brainstem
gliomas.
BPA expands the brainstem and is typically associated with
an exophytic growth, usually from its dorsal surface [20, 31]. It
is characterised by sharp margins with cyst-like areas. The
dorsal extension is a result of the inability of the low-grade
tumour to infiltrate caudally below the decussations of the
corticospinal tracts and medial lemnisci at the craniocervical
junction. Therefore, dorsally exophytic tumours should be con-
sidered focal BSTs. However, ventral exophytic PAs have also
been observed. Diffusely infiltrative brainstem gliomas are usu-
ally fibrillary astrocytomas located in the ventral pons, which
present with abducens palsy, often engulf the basilar artery, and
are associated with a grim prognosis [32]. Symptoms and signs
are usually related to increased intracranial pressure. Nausea,
vomiting, and ataxia with evidence of torticollis, papilledema,
and nystagmus palsies of the sixth and seventh cranial nerves
are usually observed at physical examination.
On CT BPA presents as a heterogeneous mass that expands
the pons, distorts the fourth ventricle, and results in a degree of
hydrocephalus. The mass is predominantly of low attenuation,
with areas of intense enhancement on postcontrast images.
BPAs are very bright on T2-weighted MRI. Thus, they can be
differentiated from ependymomas, which are isodense to grey
matter on CTand isointense on T2-weightedMRI. In addition,
dorsally exophytic tumours have been observed to push the
fourth ventricle upward, in contrast to ependymomas, which
originate within the wall of the fourth ventricle and expand it.
After the administration of contrast media, BPA exhibits in-
consistently homogeneous or heterogeneous enhancement
(Figs. 9, 10, and 11).
Proton MRS and perfusion imaging may be useful to
differentiate low-grade PA from high-grade tumours in that
lower grade glial tumours have lower choline peaks and
smaller blood volume than higher grade glial tumours
(Fig. 9f,g). However, pilocytic astrocytomas may have rela-
tively high choline and lactate peaks and relatively high blood
volumes, thus mimicking high-grade tumours (Fig. 10c,d).
The distinction between the more biologically aggressive
fibrillary astrocytoma and PA is more than an academic curi-
osity, since the fibrillary brainstem astrocytoma is associated
with a dismal prognosis compared with the excellent outlook
associated with the pilocytic variety [33].
Fig. 13 Pilomyxoid astrocytoma in a 5-year-old girl. a An axial FLAIR
image shows a large solid lobulated suprasellar mass with uniform
hyperintensity (arrows). Postgadolinium sagittal (b) and coronal (c) T1-
weighted images reveal a homogeneously enhancing suprasellar infiltra-
tive tumour (arrows)
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Management of BPA is a difficult challenge. Surgical treat-
ment must cope with the difficulties of both deep location and
eloquent area tumours. The tumour can be controlled by
partial surgical removal, and a residual tumour can sometimes
decrease in size after surgery. Gross total removal of these
tumours, although difficult, may be performed [34].
BPA is associated with a relatively good prognosis in
children and adults [32, 35]. Ahmed et al. recently reported
long-term overall survival of 14.8 years in a series of 48
children, with respective 1-, 5-, and 10-year overall survival
rates of 85 %, 67 %, and 59 % [36].
Supratentorial manifestations
Chiasmatic/hypothalamic PA
Gliomas originating in the optic chiasm often enlarge and
involve the hypothalamus; similarly, astrocytomas arising in
the hypothalamus often grow anteriorly and inferiorly to in-
volve the optic chiasm. Because the primary site of origin
cannot be determined in many cases, tumours arising from
these two locations are often discussed together. Astrocytomas
of the optic chiasm and hypothalamus make up 10 % to 15 %
of supratentorial tumours in children; males and females are
approximately equally affected. One-third of patients have
neurofibromatosis type 1 (NF1) [37].
The most common symptom of hypothalamic/optic path-
way PA is diminished visual acuity. Endocrine dysfunction,
most commonly short stature secondary to reduced growth
hormone, is usually observed. Large tumours produce hydro-
cephalus secondary to extension into the anterior third ventri-
cle and obstruction at the level of the foramen of Monro.
MRI provides precise demarcation of tumour extension
and in many cases allows accurate preoperative diagnosis
based on MRI findings [38]. Involvement of the optic path-
way causes enlargement of the optic chiasm, nerve, and tracts.
Chiasmatic/hypothalamic PAs are hypointense on T1-
Fig. 14 A pilocytic astrocytoma
of the optic nerve in a 3-year-old
girl with NF1. a An axial T2-
weighted image reveals
characteristic kinking of the
enlarged right optic nerve within
the intraconal compartment and
enlargement (arrow) of the
posterior extraconal
compartment. Note the
characteristic NF1 bright lesions
in the cerebellar hemispheres
(arrowheads). b A coronal STIR
image shows the enlarged right
optic nerve (arrow) in comparison
with the normal left optic nerve
(arrowhead). On these contrast-
enhanced axial (c) and sagittal (d)
T1-weighted images, intense
enhancement of the extraconal
component is observed (arrows)
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weighted sequence and hyperintense on T2-weighted and
FLAIR sequences. When large and bulky, tumours are typi-
cally heterogeneous and mainly solid, with mild or marked
enhancement after the intravenous administration of contrast
media (Fig. 12). Using fat-suppression techniques to eliminate
fat signal from the skull base can increase the value of
contrast-enhanced MR images of this area.
Cystic areas and trapped pools of CSF are sometimes
noted. The indolent growth rate of chiasmatic/hypothalamic
PA and its tendency to infiltrate along the arachnoid with
secondary fibrotic changes might explain the secondary de-
velopment of arachnoid cysts (Fig. 12). This phenomenon has
not been reported in association with other brain tumours [9].
Differential diagnosis in children should include
craniopharyngioma, germinoma, and Langerhans cell
histiocytosis. In adults, differential diagnosis should include
p i t u i t a r y mac r o ad enoma , s e l l a r men i ng i oma ,
craniopharingioma, metastases (more often from breast and
lung primary tumours), and lymphoma [39].
PMA is a rare variant of PA. It develops more frequently in
the suprasellar area. PMAs are more aggressive masses and
are mainly solid with uniform or heterogeneous rim enhance-
ment. They exhibit higher rates of intratumoral haemorrhage
and frequent local recurrence, and are often associated with
leptomeningeal dissemination [40] (Fig. 13). Chiasmatic/
hypothalamic PMAs reportedly display higher choline/Cr ra-
tios outside their enhancing tumour margins, which likely
reflects their more aggressive behaviour [41].
The goal of surgery in cases of chiasmatic/hypothalamic
PA is primarily to establish a histological diagnosis; if a
typical low-grade astrocytoma is encountered, then limited
resection is performed. Largemasses that obstruct the foramen
of Monro are debulked to relieve ventricular obstruction. The
majority of such patients respond to platinum-based chemo-
therapy. Chemotherapy can also improve serious visual dys-
function, and a chemotherapy-first strategy can preserve the
cognitive outcome of patients, who thereby avoid the need for
radiotherapy [42]. Chemotherapy and radiation therapy can
provide good control of the disease, with 5-year overall sur-
vival reported at >90 % [43]. Even when leptomeningeal
gliomatosis presents, craniospinal irradiation and temozolo-
mide can be very effective in disease control [44].
Optic nerve PA
Anterior optic pathway gliomas are usually PAs presenting
during the first decade of life. More than one-half of patients
have NF1 [45]. Segal et al. [46] reviewed 331 patients with
NF1 and reported the development of optic nerve glioma in
13 % of them. Bilateral tumours are almost pathognomonic
for NF1.
Anterior optic pathway PA exhibits different biological
behaviour in patients with and without NF1. Isolated optic
involvement, preservation of the optic nerve configuration,
smaller tumour size, absence of symptoms, stability or slow
growth, and even spontaneous regression are more often
observed in patients with NF1. In comparison, chiasmal in-
volvement, altered optic nerve configuration, greater tumour
size, presence of symptoms, and local growth are more often
encountered in patients without NF1 [45, 47].
MRI displays fusiform enlargement of the optic nerve,
usually with kinking or tortuosity and contrast enhancement
after the intravenous administration of gadolinium (Fig. 14).
Infiltration of the perineural subarachnoid space, cystic com-
ponents, and optic canal enlargement are sometimes observed.
Fig. 15 Classical appearance of a hemispheric pilocytic astrocytoma in a
45-year-old man. a An axial T2-weighted image demonstrates a hyper-
intense cystic component and a less hyperintense solid nodule within the
lateral ventricle (arrows). bA contrast-enhanced axial T1-weighted image
reveals intense enhancement of the solid nodule (arrows) and lack of
enhancement of the cystic portion
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Treatment is required only in symptomatic, growing tu-
mours. Resection is reserved for eyes with poor or absent
vision, for cosmetic reasons, or because of exposure keratop-
athy. Radiotherapy and chemotherapy can be used to control
tumour growth; however, radiotherapy should be avoided in
patients younger than 5 years of age [48].
The prognosis for anterior optic pathway gliomas is very
good; a 10-year progression-free survival rate of 72 % has
been reported (in contrast to 58 % for posterior optic pathway
gliomas) [49].
Hemispheric PA
Among the various age groups of patients with PA, the
major tumour location differs in prevalence. In children,
up to 67 % of patients present with cerebellar lesions;
in adults, approximately 55 % of patients present with
supratentorial lesions. Although juvenile PAs are less
common in the cerebral hemisphere, they constitute
20 % of supratentorial brain tumours.
Headache, seizure activity, hemiparesis, ataxia, nausea, and
vomiting are common clinical manifestations of hemispheric
pilocytic astrocytomas (HPAs). The occurrence of seizure
activity generally indicates cortical grey matter involvement
[9]. The tumours have no characteristic location, although in
the paediatric population they tend to occur deep within the
hemispheres and involve the basal ganglia or thalamus more
frequently than do adult tumours.
The most characteristic imaging finding is a cystic mass
with an enhancing mural nodule, usually contiguous with the
ventricular system. In one-half of HPA cases, the nodule has a
deep location (Fig. 15). However, HPAs usually appear as
medially located masses that are very hyperintense on T2-
weighted and FLAIR images. They elicit little or no vasogenic
oedema in the surrounding white matter and enhance after the
injection of gadolinium [49]. The enhancement of the solid
component of PA may be due to rich vascularity or to focal
disturbance of the blood–brain barrier [50] (Figs. 16 and 17).
Spontaneous intratumoral haemorrhage has also been de-
scribed [51]. Mixed pilocytic and fibrillary astrocytomas are
encountered; malignant transformation of a PA rarely occurs
[6]. On diffusion-weighted imaging, solid areas of HPA have
higher ADC values than high-grade hemispheric tumours [52]
(Figs. 16c and 17c).
Previous reports ofMRS performed on solid portions of PA
tumours have documented elevations in the choline-to-NAA
ratio [53] to a lesser extent than in higher grade neoplasms
(Fig. 16f,g). The well-known positive correlation between
Fig. 16 Hemispheric pilocytic astrocytomas in a 26-year-old man. a An
axial T2-weighted image shows a temporally located, lobular mass that is
very hyperintense (arrows) without vasogenic oedema. b On this T1-
weighted image, the lesion is hypointense compared with grey matter
(arrows). c The lesion exhibits low signal on diffusion-weighted imaging,
with high signal intensity on an ADC map (d). e On this post-contrast,
T1-weighted image, nodular (arrow) and peripheral rim enhancements
(arrowheads) are visible. f, gMRS with TE 144 ms revealed an elevated
choline peak without reduction of the NAA peak. h Perfusion MRI
reveals low rCBV in the solid (enhanced) part of the tumour
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increased choline levels and the glioma grade appears to be
violated by WHO grade I PAs, which exhibit a wide range of
choline values, with a marked increase in some cases. No
significant differences have been identified in MRS metabo-
lite profiles between paediatric and adult PAs [54].
PAs have a low maximum rCBV ratio (<1.5) and exhibit a
characteristic type of signal intensity time curve with an
increase in signal intensity above baseline caused by the
massive leakage of contrast medium into the interstitial space
[51] (Fig. 16h). Differential diagnosis should include other
glial tumours, as well as metastases in adults and primitive
neuroectodermal tumours in children. While high-grade glio-
mas are usually characterised by irregular margins and
perifocal oedema, haemorrhagic features have also been en-
countered. Fibrillary astrocytomas, oligodendrogliomas, and
gangliogliomas usually do not display the marked enhance-
ment observed in PA. Calcifications have been detected in
oligodendrogliomas and gangliogliomas, as well as
scalloping/erosion of the inner table of the calvaria in cases
of peripherally located tumours.
The first-line therapy for HPA is complete surgical resec-
tion. Adjuvant chemotherapy and radiotherapy are reserved
for recurrent or progressive inoperable disease.
Conclusion
In summary, this pictorial review presents imaging appear-
ances and the differential diagnosis of PA according to tumour
location. MRI with conventional sequences and advanced
techniques provides useful information regarding characteris-
tics of this low-grade tumour. HighADC values can be used in
the clinical setting as a reliable factor indicating low cellularity
of PA. Metabolite ratios of MRS and rCBV measurements on
perfusion exhibit inferior diagnostic performance, since
pilocytic astrocytomas may have relatively high choline and
lactate peaks and relatively high blood volumes, thus mim-
icking high-grade tumours. Recognition of radiologic features
and familiarity with the clinical course and sites of potential
Fig. 17 Supratentorial pilocytic astrocytomawith solid enhancement and
vasogenic oedema. a An axial T1-weighted image shows a well-
circumscribed, hypointense cerebral mass (arrows). b An axial T2-
weighted image shows a hyperintense mass. Note the vasogenic oedema
around the mass (arrows). c The lesion exhibits low signal on diffusion-
weighted imaging. Contrast-enhanced axial (d) and (e) T1-weighted
images demonstrate inhomogeneous enhancement of the mass
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involvement are essential for making the correct diagnosis and
helpful for management decisions.
Open Access This article is distributed under the terms of the Creative
Commons Attribution License which permits any use, distribution, and
reproduction in any medium, provided the original author(s) and the
source are credited.
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